

The main topic for discussion is: are immunoglobulins needed and in what clinical cases?
A group of experts, which included 20 leading anesthesiologists and resuscitators, headed by the President of the Association of Anesthesiologists and Resuscitators, Academician Y.S. Polushin, discussed the possibilities and prospects of using immunoglobulins in general and Pentoglobin in particular in the treatment of sepsis.
The meeting was opened by the President of the Association, Academician of the Russian Academy of Sciences Yuri Sergeevich Polushin. Then the members of the association made presentations in which they analyzed in detail the possibilities and prospects of using immunoglobulin in the treatment of sepsis, pediatric hematology, as well as typical errors in the treatment of patients in critical condition and the ability of hospitals to receive sufficient funding for this severe category of patients. In particular, they talked about the effectiveness of the drug Pentoglobin.
Following the meeting, the expert council confirmed the expediency of using enriched immunoglobulins in clinical practice for patients with sepsis for certain cases, and also considered it necessary to conduct observational studies in order to clarify the criteria for prescribing.
Immunobiology is one of the key areas of activity for MEDIPAL, and the topic of sepsis treatment remains relevant for the medical community to this day. The disease suddenly and powerfully attacks the human body: all organs and systems suffer. If sepsis is not treated, the outcome will be fatal. That is why it is so important to diagnose and treat sepsis in time, use all modern methods and technologies based on the latest data, in order to ensure a speedy recovery of the patient with minimal consequences.
The meeting was held in public: more than 550 people joined the online broadcast.
The saved record is available at the link..

We use cookies to analyze events on our website, which allows us to improve the site's performance. If you do not want your data to be processed, please disable cookies in your browser settings. By continuing to use our site, you accept its terms of use and give your consent to the processing of cookies. For more detailed information on the use of cookies and how to opt out, please refer to our Cookie Policy.